Related content

Do RANKL inhibitors (denosumab) affect inflammation and immunity?

By Ferrari-Lacraz S.   Ferrari S.  

Osteoporosis International, Vol. 22, Iss. 2, 2011-02 ,pp. : 435-446

Springer Publishing Company

Access to resources Recommend Favorite

mTOR Inhibitors and Calcineurin Inhibitors Do Not Affect Adhesion Molecule Expression of Human Macro- and Microvascular Endothelial Cells

By  

Journal of Vascular Research, Vol. 45, Iss. 4, 2008-03 ,pp. : 333-342

Karger

Access to resources Recommend Favorite

Innate Immunity and Airway Inflammation

By  

Journal of Innate Immunity, Vol. 2, Iss. 2, 2009-12 ,pp. : 95-95

Karger

Access to resources Recommend Favorite

Erratum to: Increased risk of serious infections in women with osteopenia or osteoporosis treated with denosumab

By Toulis K.   Anastasilakis A.  

Osteoporosis International, Vol. 21, Iss. 11, 2010-11 ,pp. : 1965-1965

Springer Publishing Company

Access to resources Recommend Favorite

Inflammatory Caspases in Innate Immunity and Inflammation

By  

Journal of Innate Immunity, Vol. 2, Iss. 3, 2010-02 ,pp. : 228-237

Karger

Access to resources Recommend Favorite